Decade Capital Management’s Pacira BioSciences PCRX Stock Holding History

Decade Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$21K	Sell	501 -99,499	-99%	-$6.09M	﹤0.01%	120
2015 Q2	$7.07M	Buy	+100,000	New	+$7.88M	0.85%	42
2013 Q4	–	Sell	-30,000	Closed	-$1.44M	–	236
2013 Q3	$1.44M	Buy	+30,000	New	+$1.09M	0.08%	146

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Decade Capital Management's PCRX Position: Q3 2015 in Review

Decade Capital Management reduced its Pacira BioSciences (PCRX) stake by 99% in Q3 2015, selling an estimated $6.09M and leaving 501 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #120.

Decade Capital Management first reported a position in PCRX in Q3 2013 and has held it in 3 quarters since. The position peaked at $7.07M in Q2 2015. 177 funds tracked by Wall St. Rank hold PCRX as of Q3 2015.

Decade Capital Management held 501 shares of Pacira BioSciences worth $21K as of Q3 2015.
Decade Capital Management sold 99,499 Pacira BioSciences shares in Q3 2015, an estimated $6.09M.
Pacira BioSciences made up ﹤0.01% of Decade Capital Management's portfolio in Q3 2015, its #120 holding.
Decade Capital Management first reported a position in Pacira BioSciences in Q3 2013 and has held it in 3 quarters since.
Decade Capital Management's Pacira BioSciences position peaked at $7.07M in Q2 2015.
177 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2015.

Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.